[{"Assets_0_FY_USD":441400000.0,"CommonStockSharesOutstanding_0_FY_shares":54381000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-201052000.0,"NetIncomeLoss_1_FY_USD":-86922000.0,"NetIncomeLoss_4_FY_USD":-285405000.0,"StockholdersEquity_0_FY_USD":115178000.0,"Ticker":"TBPH","CIK":"1583107","name":"THERAVANCE BIOPHARMA, INC.","OfficialName":"Theravance Biopharma Inc. Ordinary Shares","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688048421.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180228"}]